Amwill Healthcare IPO Day 1: Subscription Status, GMP, Offer Size, Price Band And More
Amwill Healthcare IPO was subscribed 1.04 times on Wednesday, as per the market tracking site Chittorgarh.
Amwill Healthcare Ltd. launched its initial public offering on Wednesday, joining the growing list of SME IPOs opening in February. The company aims to raise Rs 60 crore from the primary market through its IPO. As the IPO opens for subscription, here are key details that investors must know about Amwill Healthcare IPO:
Amwill Healthcare IPO: Key Details
The Amwill Healthcare IPO, open between Feb. 5 and Feb. 7, aims to mop up Rs 59.98 crore from the primary markets. The BSE SME IPO is a combination of a fresh offer of 44.04 lakh shares worth Rs 48.88 crore and an offer for sale of 10 lakh shares amounting to Rs 11 crore.
Share allotment for the IPO, priced at Rs 105 to Rs 111 per share, is likely to be done on Monday, Feb 10. Successful bidders will get their credit of shares to Demat accounts on Feb. 11 and refunds will be initiated to non-allottees on the same day.
The company has reserved 40% of its share offerings each for retail investors and non-institutional investors, and the remaining 20% for qualified institutional buyers.
Retail investors have to apply for at least 1,200 shares in one lot. This takes the minimum investment amount to Rs 1,33,200 for a single lot application.
The company has appointed Bigshare Services Pvt. as the registrar for the issue, while Unistone Capital Pvt. will act as the book-running lead manager. Globalworth Securities Ltd. is the issue's market maker.
Shares of Amwill Healthcare are likely to be listed on BSE SME on Wednesday, Feb. 12.
Amwill Healthcare IPO Subscription Status: Day 1
Amwill Healthcare IPO was subscribed 1.04 times on Wednesday, as per the market tracking site Chittorgarh:
Qualified Institutions: 2.19 times
Non-Institutional Investors: 0.51 times
Retail Investors: 1 times
*The subscription status will be updated at regular intervals
Amwill Healthcare IPO GMP Today
Amwill Healthcare IPO GMP (grey market premium) was Rs 6 apiece on Feb. 5, as per InvestorGain. This projects a listing gain of 5.41% over the issue price, with the debut price of each share being Rs 117.
Note: GMP or grey market price is not an official price quote for the stock and is based on speculation.
Amwill Healthcare: Business And Financials
Amwill Healthcare Ltd. is a derma-cosmetic development firm. It makes collaborations with contract manufacturers, distributors, and third-party product development agencies to market its products.
The company makes skin-related products to manage conditions like acne, fungal infections, anti-ageing, histaminic, periorbital hyperpigmentation, scabies, perspiration, trichology and vitiligo.
Use Of Proceeds
Amwill Healthcare will use the funds from its IPO to meet working capital needs, engage in marketing and brand-building activities and for general corporate purposes.
Financials
Amwill Healthcare Ltd. posted a revenue of Rs 23.25 crore and a net profit of Rs 6.52 crore during the period ended Sept. 30, 2024. In FY24, its revenue jumped over 46%% to Rs 44.28 crore from Rs 30.28 crore in FY23. The net profit skyrocketed 303% year-on-year to Rs 12.54 crore from Rs 3.11 crore.
Disclaimer: Investments in initial public offerings are subject to market risks. Please consult with financial advisors and read the red herring prospectus thoroughly before placing bids.
